Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: Study ALL10 From the Dutch Childhood Oncology Group - Pieters, R; de Groot-Kruseman, H; Van der Velden, V (J Clin Oncol, 2016)
, et al.